All Rankings

Top 100 Biotech Companies 2026

Private biotechnology and genomics companies, ranked by disclosed lifetime funding.

Known total funding for 100 of 100 ranked companies: $70.3B.

Showing top 100 matching companies · Ranked by total funding raised

Use company data through the API.
Example request
curl "https://indexed.vc/api/v1/companies?industries=Biotech,Genomics&operatingStatus=active&sort=total_funding_raised&order=desc&limit=100" -H "X-API-Key: YOUR_API_KEY"

The API has no company type filter, so public companies can appear; this list counts private companies only.

The API cannot leave out companies whose latest round is a grant; this list does.

Data from Indexed.vcUpdated

Methodology: up to 100 active companies matching this list's filters are ordered by disclosed total funding in USD. Companies whose latest round is one of: Grant are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

26
Perfect Day

Sustainable dairy protein from precision fermentation

Berkeley, United States51–200Biotech
Series ETotal funding$787.7MJan 2024
27
NewLimit

NewLimit develops medicines that unlock cellular regenerative potential to extend human healthspa...

South San Francisco, United States11–50Biotech, Healthcare
Venture RoundTotal funding$735.0MJun 2026
28
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
29
Solugen

Solugen manufactures lower-carbon specialty chemicals using its Bioforge platform, combining enzy...

Houston, United States51–200Biotech, Climate Tech
Venture RoundTotal funding$695.7MMar 2026
30
Kriya Therapeutics

Kriya integrates product engineering, analytics, and manufacturing to develop scalable gene thera...

Research Triangle Park, United States51–200Biotech, Healthcare
Series DTotal funding$655.0MSep 2025
31
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
32
insitro

High-quality perturbational data generation and AI to discover new targets and enable drug discov...

South San Francisco, United States201–500Artificial Intelligence, Healthcare
Series CTotal funding$643.0MMar 2021
33
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Series CTotal funding$630.0MJul 2026
34
Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United States501–1000Life Sciences, Biotech
Series ETotal funding$614.0MNov 2021
35
Varda

In-space pharmaceutical manufacturing company that designs, builds, and flies spacecraft to proce...

El Segundo, United States51–200Biotech, Manufacturing
Series DTotal funding$610.3MSep 2026
36
TrialSpark

Clinical trial site network and operations

New York, United States51–200Biotech, Healthcare
Series CTotal funding$598.0MJan 2024
37
UPSIDE Foods

UPSIDE Foods grows cultivated chicken from animal cells in nutrient-fed tanks, producing real mea...

Berkeley, United States201–500Biotech, Food Tech
Series CTotal funding$583.0MApr 2022
38
Colossal Biosciences

De-extinction and genetic engineering company working to bring back the woolly mammoth and other ...

Dallas, United States51–200Biotech
Series DTotal funding$583.0MSep 2025
39
Corxel

Corxel develops innovative therapies for patients with cardiometabolic conditions worldwide, adva...

United States51–200Biotech, Healthcare
Series DTotal funding$581.5MJan 2026
40
Rakuten Medical

Global biotechnology company developing and commercializing precision, cell-targeting therapies b...

San Diego, United States51–200Biotech, Life Sciences
Series FTotal funding$575.0MJan 2026
41
Aviceda

World leader in glyco-immune checkpoint therapeutics developing immune-mediated therapies for pat...

Cambridge, United States51–200Biotech, Healthcare
Series CTotal funding$572.6MJan 2025
42
Nimbus Therapeutics

Nimbus Therapeutics is a clinical-stage biotech developing novel small molecule medicines using s...

Cambridge, United States51–200Biotech, Healthcare
Growth EquityTotal funding$572.0MSep 2023
43
DNAnexus

Provides a cloud-based precision-health platform to manage, analyze, and collaborate on multi-omi...

Mountain View, United States201–500Data & Analytics, Developer Tools
Series G+Total funding$572.0MMar 2022
44
Orca Bio

Orca Bio develops precision allogeneic cell therapies that use regulatory T cells to improve outc...

Menlo Park, United States51–200Biotech, Healthcare
Series FTotal funding$567.0MDec 2025
45
Cardurion

Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and ...

Burlington, United States11–50Biotech, Healthcare
Series BTotal funding$560.0MJul 2024
46
Freenome

Freenome develops blood-based cancer screening tests using computational biology, machine learnin...

South San Francisco, United States501–1000Artificial Intelligence, Biotech
Series ETotal funding$554.0MFeb 2024
47
Encoded Therapeutics

Gene therapy company developing precision gene therapies for debilitating neurological disorders,...

South San Francisco, United States51–200Biotech, Therapeutics
Series FTotal funding$514.0MSep 2026
48
Angitia Biopharmaceuticals

Angitia Biopharmaceuticals is a clinical-stage biotechnology company developing innovative therap...

Westlake Village, United States51–200Biotech, Healthcare
Series DTotal funding$506.0MFeb 2026
49
Piramal Pharma

India-based pharmaceutical company offering CDMO services, critical care products, and consumer h...

Mumbai, India10001+Biotech, Healthcare
Corporate RoundTotal funding$490.0MJun 2020
50
Abcuro

Abcuro is a clinical-stage company developing Ulviprubart, a FIC anti-KLRG1 antibody in Ph2/3 piv...

Newton, United States51–200Biotech, Healthcare
Series DTotal funding$473.3MAug 2026